Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPH-02769 |
LY6G Protein, Mouse, Recombinant (His)
Ly-6G.1,Lymphocyte antigen 6G... |
Mouse | P. pastoris (Yeast) |
N/A. LY6G Protein, Mouse, Recombinant (His) is expressed in yeast with N-6xHis tag. The predicted molecular weight is 11.9 kDa and the accession number is P35461. | |||
TMPH-02768 |
LY6G Protein, Mouse, Recombinant (E. coli, His)
Lymphocyte antigen 6G,Ly-6G |
Mouse | E. coli |
N/A. LY6G Protein, Mouse, Recombinant (E. coli, His) is expressed in E. coli expression system with N-10xHis tag. The predicted molecular weight is 13.4 kDa and the accession number is P35461. | |||
TMPK-01007 |
LY6G6F Protein, Human, Recombinant (hFc)
G6F,C6orf21,NG32,LY6G6D |
Human | HEK293 Cells |
The human G6f protein, which is encoded by a gene in the MHC, is a putative cell-surface receptor belonging to the immunoglobulin superfamily. | |||
TMPK-00752 |
LY6G6D Protein, Human, Recombinant (hFc)
G6D,MEGT1,C6orf23,NG25,Protein Ly6-D,Ly6-D |
Human | HEK293 Cells |
LY6G6D is a selectively expressed colorectal cancer antigen that can be used for targeting a therapeutic T-cell response by a T-cell engager.LY6G6D was identified as a selectively expressed CRC antigen that can be utilized to potently re-direct and activate cytotoxic T-cells to lyse LY6G6D expressing CRC using a TcE. This effect can be spread to target negative neighboring tumor cells, potentially leading to improved therapeutic efficacy. LY6G6D Protein, Human, Recombinant (hFc) is expressed in ... | |||
TMPH-02433 |
LY6G6D Protein, Cynomolgus, Recombinant (Yeast, His)
|
Cynomolgus | P. pastoris (Yeast) |
LY6G6D Protein, Cynomolgus, Recombinant (Yeast, His) is expressed in yeast with N-6xHis tag. The predicted molecular weight is 11.1 kDa and the accession number is UJY53414.1. | |||
TMPK-00753 |
LY6G6D Protein, Human, Recombinant (His)
C6orf23,Ly6-D,NG25,G6D,Protein Ly6-D,MEGT1 |
Human | HEK293 Cells |
LY6G6D is a selectively expressed colorectal cancer antigen that can be used for targeting a therapeutic T-cell response by a T-cell engager.LY6G6D was identified as a selectively expressed CRC antigen that can be utilized to potently re-direct and activate cytotoxic T-cells to lyse LY6G6D expressing CRC using a TcE. This effect can be spread to target negative neighboring tumor cells, potentially leading to improved therapeutic efficacy. LY6G6D Protein, Human, Recombinant (His) is expressed in ... | |||
TMPK-01332 |
LY6G6D Protein, Cynomolgus, Recombinant (His)
Ly6-D,C6orf23,G6D,MEGT1,NG25,Protein Ly6-D |
Cynomolgus | HEK293 Cells |
LY6G6D is a selectively expressed colorectal cancer antigen that can be used for targeting a therapeutic T-cell response by a T-cell engager.LY6G6D was identified as a selectively expressed CRC antigen that can be utilized to potently re-direct and activate cytotoxic T-cells to lyse LY6G6D expressing CRC using a TcE. This effect can be spread to target negative neighboring tumor cells, potentially leading to improved therapeutic efficacy. LY6G6D Protein, Cynomolgus, Recombinant (His) is expresse... | |||
TMPK-00754 |
LY6G6D Protein, Human, Recombinant (His & Strep-II)
C6orf23,MEGT1,Protein Ly6-D,NG25,G6D,Ly6-D |
Human | HEK293 Cells |
LY6G6D is a selectively expressed colorectal cancer antigen that can be used for targeting a therapeutic T-cell response by a T-cell engager.LY6G6D was identified as a selectively expressed CRC antigen that can be utilized to potently re-direct and activate cytotoxic T-cells to lyse LY6G6D expressing CRC using a TcE. This effect can be spread to target negative neighboring tumor cells, potentially leading to improved therapeutic efficacy. LY6G6D Protein, Human, Recombinant (His & Strep-II) is ex... |